| __timestamp | Amneal Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 33472000 |
| Thursday, January 1, 2015 | 136870000 | 47368000 |
| Friday, January 1, 2016 | 204747000 | 66871000 |
| Sunday, January 1, 2017 | 191938000 | 50675000 |
| Monday, January 1, 2018 | 210451000 | 78821000 |
| Tuesday, January 1, 2019 | 202287000 | 91944000 |
| Wednesday, January 1, 2020 | 190585000 | 111234000 |
| Friday, January 1, 2021 | 209563000 | 207447000 |
| Saturday, January 1, 2022 | 200046000 | 267587000 |
| Sunday, January 1, 2023 | 167778000 | 303055000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is key. Amneal Pharmaceuticals, Inc. and HUTCHMED (China) Limited have been investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Amneal's R&D expenses grew by approximately 57%, peaking in 2018. Meanwhile, HUTCHMED's investment skyrocketed by nearly 805%, with a notable surge in 2023, surpassing Amneal by 80%. This trend highlights HUTCHMED's aggressive push towards innovation, especially in recent years. While Amneal maintained a steady investment, HUTCHMED's exponential growth in R&D spending signals its commitment to pioneering advancements in the pharmaceutical industry. As these companies continue to innovate, their strategic investments in R&D will likely shape the future of healthcare solutions globally.
Research and Development: Comparing Key Metrics for Novartis AG and HUTCHMED (China) Limited
argenx SE vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and HUTCHMED (China) Limited
R&D Spending Showdown: Insmed Incorporated vs HUTCHMED (China) Limited
Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Amneal Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Research and Development Expenses Breakdown: Ultragenyx Pharmaceutical Inc. vs HUTCHMED (China) Limited
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Amphastar Pharmaceuticals, Inc.